Intro

This chapter explores significant findings from the American Diabetes Association’s annual conference, highlighting breakthroughs in diabetes treatments and research on GLP-1 receptor agonists. It emphasizes the rising interest in obesity treatments, particularly the potential of terzepatide to alleviate symptoms of obstructive sleep apnea, impacting millions.